vs

Side-by-side financial comparison of FENNEC PHARMACEUTICALS INC. (FENC) and Omega Flex, Inc. (OFLX). Click either name above to swap in a different company.

Omega Flex, Inc. is the larger business by last-quarter revenue ($25.2M vs $13.8M, roughly 1.8× FENNEC PHARMACEUTICALS INC.). Omega Flex, Inc. runs the higher net margin — 13.5% vs -34.7%, a 48.3% gap on every dollar of revenue. On growth, FENNEC PHARMACEUTICALS INC. posted the faster year-over-year revenue change (73.8% vs -6.5%). Over the past eight quarters, Omega Flex, Inc.'s revenue compounded faster (-0.0% CAGR vs -26.3%).

Fennec Pharmaceuticals Inc. is a biopharmaceutical firm focused on developing and commercializing therapies to reduce treatment-related side effects in pediatric cancer patients. Its lead product targets chemotherapy-induced ototoxicity, with core North American markets serving oncology providers and vulnerable pediatric patient groups.

Smart Omega Esports, formerly known as PLDT–Smart Omega, is a Philippine franchise-based professional esports team which competes in The Nationals, the top esports league in the Philippines sanctioned by the eSports National Association of the Philippines, and MPL Philippines. It was formed as a result of a partnership between esports team Sterling Global Dragons and corporate firms, PLDT Inc. and its mobile arm, Smart Communications.

FENC vs OFLX — Head-to-Head

Bigger by revenue
OFLX
OFLX
1.8× larger
OFLX
$25.2M
$13.8M
FENC
Growing faster (revenue YoY)
FENC
FENC
+80.4% gap
FENC
73.8%
-6.5%
OFLX
Higher net margin
OFLX
OFLX
48.3% more per $
OFLX
13.5%
-34.7%
FENC
Faster 2-yr revenue CAGR
OFLX
OFLX
Annualised
OFLX
-0.0%
-26.3%
FENC

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FENC
FENC
OFLX
OFLX
Revenue
$13.8M
$25.2M
Net Profit
$-4.8M
$3.4M
Gross Margin
59.2%
Operating Margin
-18.5%
15.8%
Net Margin
-34.7%
13.5%
Revenue YoY
73.8%
-6.5%
Net Profit YoY
-141.1%
-27.1%
EPS (diluted)
$-0.17
$0.34

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FENC
FENC
OFLX
OFLX
Q4 25
$13.8M
$25.2M
Q3 25
$12.5M
$24.2M
Q2 25
$9.7M
$25.5M
Q1 25
$8.8M
$23.3M
Q4 24
$7.9M
$27.0M
Q3 24
$7.0M
$24.9M
Q2 24
$7.3M
$24.6M
Q1 24
$25.4M
$25.2M
Net Profit
FENC
FENC
OFLX
OFLX
Q4 25
$-4.8M
$3.4M
Q3 25
$-638.0K
$3.7M
Q2 25
$-3.2M
$4.2M
Q1 25
$-1.2M
$3.6M
Q4 24
$-2.0M
$4.7M
Q3 24
$-5.7M
$4.6M
Q2 24
$-5.6M
$4.5M
Q1 24
$12.8M
$4.2M
Gross Margin
FENC
FENC
OFLX
OFLX
Q4 25
59.2%
Q3 25
60.2%
Q2 25
60.4%
Q1 25
60.3%
Q4 24
61.5%
Q3 24
61.7%
Q2 24
61.8%
Q1 24
59.9%
Operating Margin
FENC
FENC
OFLX
OFLX
Q4 25
-18.5%
15.8%
Q3 25
-1.5%
17.3%
Q2 25
-28.3%
18.5%
Q1 25
-9.2%
17.4%
Q4 24
-11.8%
21.4%
Q3 24
-74.6%
22.0%
Q2 24
-69.4%
21.5%
Q1 24
54.2%
20.1%
Net Margin
FENC
FENC
OFLX
OFLX
Q4 25
-34.7%
13.5%
Q3 25
-5.1%
15.2%
Q2 25
-32.7%
16.3%
Q1 25
-13.3%
15.3%
Q4 24
-25.0%
17.4%
Q3 24
-82.2%
18.6%
Q2 24
-76.5%
18.3%
Q1 24
50.6%
16.7%
EPS (diluted)
FENC
FENC
OFLX
OFLX
Q4 25
$-0.17
$0.34
Q3 25
$-0.02
$0.37
Q2 25
$-0.11
$0.41
Q1 25
$-0.04
$0.35
Q4 24
$-0.02
$0.45
Q3 24
$-0.21
$0.46
Q2 24
$-0.20
$0.45
Q1 24
$0.41
$0.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FENC
FENC
OFLX
OFLX
Cash + ST InvestmentsLiquidity on hand
$36.8M
$53.2M
Total DebtLower is stronger
Stockholders' EquityBook value
$35.5M
$84.2M
Total Assets
$70.6M
$105.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FENC
FENC
OFLX
OFLX
Q4 25
$36.8M
$53.2M
Q3 25
$21.9M
$49.4M
Q2 25
$18.7M
$50.7M
Q1 25
$22.7M
$49.2M
Q4 24
$26.6M
$51.7M
Q3 24
$40.3M
$45.9M
Q2 24
$43.1M
$45.7M
Q1 24
$51.2M
$45.3M
Total Debt
FENC
FENC
OFLX
OFLX
Q4 25
Q3 25
$19.4M
Q2 25
$19.4M
Q1 25
$19.4M
Q4 24
$19.3M
Q3 24
$32.1M
Q2 24
$31.8M
Q1 24
$31.3M
Stockholders' Equity
FENC
FENC
OFLX
OFLX
Q4 25
$35.5M
$84.2M
Q3 25
$-4.5M
$84.2M
Q2 25
$-7.5M
$84.0M
Q1 25
$-5.9M
$83.3M
Q4 24
$-5.9M
$83.1M
Q3 24
$-5.2M
$82.0M
Q2 24
$-1.4M
$80.6M
Q1 24
$3.0M
$79.6M
Total Assets
FENC
FENC
OFLX
OFLX
Q4 25
$70.6M
$105.0M
Q3 25
$49.3M
$103.8M
Q2 25
$44.9M
$102.8M
Q1 25
$46.4M
$102.8M
Q4 24
$44.9M
$105.9M
Q3 24
$58.9M
$102.9M
Q2 24
$63.2M
$99.6M
Q1 24
$69.2M
$99.2M
Debt / Equity
FENC
FENC
OFLX
OFLX
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
10.40×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FENC
FENC
OFLX
OFLX
Operating Cash FlowLast quarter
$-6.0M
$7.5M
Free Cash FlowOCF − Capex
$7.3M
FCF MarginFCF / Revenue
28.9%
Capex IntensityCapex / Revenue
0.8%
Cash ConversionOCF / Net Profit
2.20×
TTM Free Cash FlowTrailing 4 quarters
$15.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FENC
FENC
OFLX
OFLX
Q4 25
$-6.0M
$7.5M
Q3 25
$1.5M
$2.7M
Q2 25
$-3.7M
$5.5M
Q1 25
$-4.3M
$1.6M
Q4 24
$-1.5M
$9.8M
Q3 24
$-2.2M
$4.0M
Q2 24
$-8.4M
$4.4M
Q1 24
$39.0M
$2.7M
Free Cash Flow
FENC
FENC
OFLX
OFLX
Q4 25
$7.3M
Q3 25
$2.0M
Q2 25
$5.0M
Q1 25
$1.0M
Q4 24
$9.2M
Q3 24
$3.6M
Q2 24
$3.8M
Q1 24
$2.2M
FCF Margin
FENC
FENC
OFLX
OFLX
Q4 25
28.9%
Q3 25
8.4%
Q2 25
19.6%
Q1 25
4.3%
Q4 24
34.1%
Q3 24
14.7%
Q2 24
15.3%
Q1 24
8.9%
Capex Intensity
FENC
FENC
OFLX
OFLX
Q4 25
0.8%
Q3 25
2.5%
Q2 25
1.7%
Q1 25
2.4%
Q4 24
2.1%
Q3 24
1.4%
Q2 24
2.6%
Q1 24
1.8%
Cash Conversion
FENC
FENC
OFLX
OFLX
Q4 25
2.20×
Q3 25
0.72×
Q2 25
1.31×
Q1 25
0.44×
Q4 24
2.08×
Q3 24
0.86×
Q2 24
0.98×
Q1 24
3.04×
0.64×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons